Reports Q3 adjusted EBITDA $5.694M vs. $3.465M. “In Q3, we delivered our second consecutive quarter of record revenue driven by the acquisition of Motif, Collective Project, and a further optimization of our product and brand portfolio,” said Beena Goldenberg, CEO of Organigram (OGI). “With our strong Canadian market leadership now in place, we are committed to bringing our Canadian successes, underpinned by innovation and a commitment to quality, to international markets. We have grown our export business, expanded into the US, and are set to launch new brands internationally, all building towards our ambition of becoming a truly global cannabis player.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OGI:
- Options Volatility and Implied Earnings Moves This Week, August 11 – August 14, 2025
- Organigram to Announce Q3 Fiscal 2025 Results on August 13
- Organigram Expands U.S. Presence with Hemp-Derived THC Beverage Launch
- Organigram’s Collective Project launches e-commerce platform in the U.S.
- Is OGI a Buy, Before Earnings?